Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pharmacia & Upjohn licenses rights to novel JT diabetes drug

June 24, 1998

Controlled study refutes evidence indicating that garlic lowers lipids

June 23, 1998

Lilly expands women's health pipeline

June 23, 1998

Hemosol awarded grant for Hemolink development

June 23, 1998

Symphar, SmithKline Beecham collaborate in the discovery of Lp(a)-lowering agents

June 22, 1998

Orlistat reaches first market

June 19, 1998

Sibutramine: preclinical effects on glucose homeostasis and uptake

June 19, 1998

EXO-226 effective against diabetic nephropathy in db/db mice

June 19, 1998

MD-700, a new LDL receptor-upregulating compound from Taisho

June 19, 1998

Hoe-901: new long-acting insulin for IDDM and NIDDM

June 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...